Clinical trials for Neuroendocrine tumor of pancreas
16 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07273409Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or NotUppsala University · PI: Olov Norlén, MD, PhD
- ENROLLING BY INVITATIONPhase 2NCT07121478Patients With High-grade Pancreatic Neuroendocrine TumorsNational Cancer Center, Korea · PI: Sang Myung Woo(Principal), MD
- RECRUITINGPHASE2, PHASE3NCT06943755Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsExelixis · PI: Medical Director
- RECRUITINGPhase 1NCT06663072Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine TumorsUniversity of Chicago · PI: Chih-Yi (Andy) Liao, MD
- RECRUITINGPhase 1NCT05687123Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsNational Cancer Institute (NCI) · PI: Nikolaos Trikalinos
- ACTIVE NOT RECRUITINGNCT06406387ATRX/DAXX in EUS-FNB Specimens of Pan-NETsAzienda Ospedaliera Universitaria Integrata Verona
- RECRUITINGNCT06121622Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine TumoursIRCCS San Raffaele
- ACTIVE NOT RECRUITINGEarly Phase 1NCT06148636A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine TumorsDavid Bushnell · PI: David Bushnell, MD
- RECRUITINGPhase 2NCT05997056Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsAadi Bioscience, Inc. · PI: Willis Navarro, MD
- RECRUITINGNCT05847855Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic TumorsFudan University · PI: Xianjun Yu, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05247905Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine TumorsAlliance for Clinical Trials in Oncology · PI: Timothy J. b, MD
- RECRUITINGPhase 2NCT05040360Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsSWOG Cancer Research Network · PI: Heloisa P Soares
- RECRUITINGN/ANCT05037461Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 PatientsJ.M. de Laat
- RECRUITINGPhase 3NCT05477576Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyRayzeBio, Inc. · PI: Ye Yuan, MD
- RECRUITINGN/ANCT04520932Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine TumorsInstitut Paoli-Calmettes · PI: Fabrice CAILLOL, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03600233Study of CVM-1118 for Patients With Advanced Neuroendocrine TumorsTaiRx, Inc. · PI: Wu-Chou Su